Loading
Latest filing published 02 Jan 2026 for Entera Bio Ltd.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Gerald M. Ostrov is a declared insider of Entera Bio Ltd. (board member), with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 13 January 2022 to 1 January 2026.
Every open-market trade on record is a purchase: 1 purchase worth €24k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants.
Most recently, on 2 January 2026, the filings show a share grant in Entera Bio Ltd. The latest purchase dates back some time: it was published 1,727 days ago, on 25 January 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations